LeslieRobbinsDeMarsMD
Obstetrics & Gynecology • Manchester, NHGynecologic Oncology
Associate Professor of Obstetrics & Gynecology, Dartmouth Medical School
Dr. DeMars is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
185 Queen City Ave
Manchester, NH 03101Phone+1 603-627-1102Fax+1 603-647-5524
Education & Training
University of North Carolina HospitalsResidency, Obstetrics and Gynecology, 1987 - 1991
University of Vermont College of MedicineClass of 1987
Certifications & Licensure
NH State Medical License 1997 - 2025
VT State Medical License 1998 - 2020
NC State Medical License 1990 - 2010
VA State Medical License 1994 - 2008- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Join now to see all
Clinical Trials
- Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 May 01
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
- Join now to see all
Publications & Presentations
PubMed
- 256 citationsHPV vaccines – A review of the first decadeDiane M. Harper, Leslie R. DeMars
Gynecologic Oncology. 2017-07-01 - 74 citationsPhase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer.Jonathan Oh, Minal A. Barve, Carolyn M. Matthews, E. Colin Koon, Thomas P. Heffernan
Gynecologic Oncology. 2016-12-01 - 50 citationsProgression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay.Holly H. Gallion, W.A. Christopherson, Robert L. Coleman, Leslie R. DeMars, Thomas J. Herzog
International Journal of Gynecological Cancer. 2006-01-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
